Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05093764 · ClinicalTrials.gov registry record · NA
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
A NA study of Aortic Valve Disease, sponsored by Saint Luke's Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05093764 is a NA study of Aortic Valve Disease that is actively recruiting participants, run by Saint Luke's Health System. The registered enrollment target is 20 participants, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05093764, a NA study of Aortic Valve Disease, is actively recruiting participants, sponsored by Saint Luke's Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
Conditions Studied
Interventions
- DEVICE VIV TAVR with BVF using TCEP
Study Locations (1)
Missouri
- Saint Luke's Hospital of Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05093764
The ClinicalTrials.gov registry entry for NCT05093764 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which VIV TAVR with BVF using TCEP is the first listed.
NCT05093764 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05093764 about?
NCT05093764 is a clinical study titled "Quantification of Debris Captured Using TCEP During VIV TAVR With BVF". The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
What is the current status of trial NCT05093764?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-02. Estimated completion is 2025-12-31.
What conditions does trial NCT05093764 study?
This clinical trial studies the following conditions: Aortic Valve Disease.
What interventions are being tested in trial NCT05093764?
The interventions under investigation include: VIV TAVR with BVF using TCEP (DEVICE).
Who is sponsoring clinical trial NCT05093764?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05093764 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
-
J-Valve TF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
ACTIVE NOT RECRUITING · NA
-
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.